Opaleye Management’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $23M | Buy |
|
|||||
|
2024
Q2 | $16.8M | Hold |
|
|||||
|
2024
Q1 | $24.3M | Buy |
|
|||||
|
2023
Q4 | $14.2M | Sell |
|
|||||
|
2023
Q3 | $11.5M | Buy |
|
|||||
|
2023
Q2 | $14.2M | Buy |
|
|||||
|
2023
Q1 | $10.2M | Hold |
|
|||||
|
2022
Q4 | $11.4M | Sell |
|
|||||
|
2022
Q3 | $12.1M | Buy |
|
|||||
|
2022
Q2 | $7.63M | Buy |
|
|||||
|
2022
Q1 | $14.5M | Hold |
|
|||||
|
2021
Q4 | $15.5M | Sell |
|
|||||
|
2021
Q3 | $13.9M | Buy |
|
|||||
|
2021
Q2 | $9.98M | Buy |
|
|||||
|
2021
Q1 | $9.69M | Buy |
|